Relationship of tumor leucocytic infiltration to host defense mechanisms and prognosis.
The interface between the tumor and the host is often the site of leucocytic infiltration. We will examine the idea that the infiltrating leucocytes of human and experimental tumors are components of the host immunological defense against the tumor, and that the presence of the infiltrate is a marker of favorable prognosis. Leucocytes could infiltrate tumors because of an active immune response, either nonspecific or specifically directed to tumor-associated antigens. Leucocyte influx may also occur because of chemotactic factors secreted by the tumor cells. Some tumors release factors which enhance vascular permeability and permit improved access by leucocytes to the tumor focus. The consequences of leucocytic infiltration include tumor cell cytolysis, cytostasis, or stimulation of proliferation. The present state of our knowledge of the interactions between tumor cells and infiltrating leucocytes precludes broad generalization of mechanisms. Further study will probably reveal that the mechanisms are diverse, and that there are some systems in which immune interactions occur at this interface and others in which they do not.
D000818:Animals; D001943:Breast Neoplasms / Q000473:pathology; D002199:Capillary Permeability; D002630:Chemotactic Factors / Q000502:physiology; D005260:Female; D006801:Humans; D016030:Kidney Transplantation; D007962:Leukocytes / Q000276:immunology / Q000473:pathology*; D008175:Lung Neoplasms / Q000473:pathology; D008264:Macrophages / Q000473:pathology; D008297:Male; D008545:Melanoma / Q000473:pathology; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000276:immunology / Q000473:pathology*; D009447:Neuroblastoma / Q000473:pathology; D011379:Prognosis; D051381:Rats; D013736:Testicular Neoplasms / Q000473:pathology; D014184:Transplantation, Homologous; D001749:Urinary Bladder Neoplasms / Q000473:pathology
D002630:Chemotactic Factors